The company's Executive Vice President for Europe and Canada told Euronews that once approved the vaccine could be distributed "very fast" across all EU member states.
The company's Executive Vice President for Europe and Canada told Euronews that once approved the vaccine could be distributed "very fast" across all EU member states.
British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a..